Ye, Siqin
Hiura, Grant
Fleck, Elaine
Garcia, Aury
Geleris, Joshua
Lee, Paul
Liyanage-Don, Nadia
Moise, Nathalie
Schluger, Neil
Singer, Jessica
Sobieszczyk, Magdalena
Sun, Yifei
West, Harry
Kronish, Ian M. https://orcid.org/0000-0003-0945-2380
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01-HL123368)
National Heart, Lung, and Blood Institute (R01-HL117832, R01-HL093081, R01-HL077612, R01-HL121270, R01-HL141609)
Agency for Healthcare Research and Quality (R01-HS024262)
Health Resources and Services Administration (T32-HP10260)
Agency for Healthcare Research and Quality (R01-HS025198)
Article History
Received: 17 May 2020
Accepted: 31 October 2020
First Online: 14 January 2021
Compliance with Ethical Standards
: The institutional review board of Columbia University Irving Medical Center (CUIMC) approved this case series as minimal-risk research using data collected as part of routine clinical practice and waived the requirement for informed consent.
: Dr. Geleris reports non-financial support from Allergan Inc, Alexion Pharmaceuticals, Inc, Boehringer Inhelheim Pharmaceuticals, Inc, Jansen Pharmaceuticals, Inc, Pfizer, Inc, outside the submitted work.
Free to read: This content has been made available to all.